Diversity, Representativeness and Equitable Access in DHT Deployment
Why who a device can reach is a data-validity question — and why the durable regulatory anchor is the representativeness of the enrolled population.
REGULATORY OPERATIONSA DHT is not demographically neutral: device, connectivity, interface and provisioning decide who takes part — and exclusion is a data-validity problem first.
A measure that under-samples older adults or people with low literacy or poor connectivity may not generalize to the population the product is for. Define the target population, map who the device cannot reach, design for access, test for differential performance, and record it in the RIA with the validation evidence.
Five design choices decide whether a deployment narrows or widens reach
| Design choice | How it narrows reach | How it widens reach |
|---|---|---|
| BYOD vs provisioned | BYOD assumes a suitable device and data plan | Provisioning removes the ownership barrier — if logistics reach everyone |
| Connectivity model | Always-online apps exclude low-connectivity participants | Offline-tolerant capture with later sync reaches rural / intermittent users |
| Language and literacy | Single-language, text-heavy interfaces exclude many | Multilingual, low-literacy and audio-supported designs broaden access |
| Accessibility | Small targets and no assistive support exclude impaired users | Accessible design and assistive-tech support include them |
| Support model | Self-service only assumes digital confidence | Human and helpline support keeps less-confident participants enrolled |
Four positions that move representativeness out of the equity annex
The wearable, home instrument, phone or tablet — with its connectivity, interface and provisioning route — decides who can realistically take part, and therefore who the data describe.
An endpoint from a device that under-samples part of the target may not generalize to it; a label claim resting on it is, to that extent, unsupported. Context of use includes the population.
ICH E6(R3) Principle 1.4 requires selection representative of the groups the product is intended to benefit; the CTR asks the same at assessment (Recital 14; Art. 6(1)(b)(i)).
Broad ownership is not broad access. Provisioning moves the step rather than removing it; each assumption falls hardest on the groups trials most often under-represent.
Five steps, from target population to recorded rationale
- 1Define the target population — the population the product is actually for, the reference against which representativeness is judged.
- 2Map device-driven exclusion — who the device, connectivity and interface cannot reach: age, literacy, language, connectivity, disability.
- 3Design for access — BYOD vs provisioned, offline tolerance, language, accessibility and support models that widen reach.
- 4Check for measurement bias — whether the measure or any model behind it performs differently across groups.
- 5Document the rationale in the RIA alongside the validation and qualification evidence — not in a separate equity annex.
ICH E6(R3) Principle 1.4 · CTR Recital 14, Art. 6(1)(b)(i) · FDORA (2022) Diversity Action Plans · FDA draft DAP guidance (June 2024) · HMA/EC/EMA recommendation paper v02 · FDA DHT guidance · IEC 62366-1:2015 + A1:2020
© qointa 2026 – Public – Uncontrolled when printed · Not legal advice; this summary does not classify any device.
sales@qointa.com · qointa.com
More from the library
Digital Health Technologies in Clinical Trials — A Regulatory Position-Paper Series
One device, several perimeters: a framework for assessing the regulatory impact of the technologies a trial relies on.
Read more →Who Is the Manufacturer? Economic-Operator Roles in DHT Supply Chains
How provisioning, importing, kitting and modifying a device assign manufacturer, importer and distributor duties — often by operation of law.
Read more →You Can Delegate the Work, Not the Accountability: Vendor Qualification and Oversight under ICH E6(R3)
The sponsor’s duty to qualify and oversee its DHT vendors — distinct from who holds the economic-operator role.
Read more →Talk to a specialist
Bring one device and one protocol — a wearable, a sensor, an app, anything. We will tell you which regulatory perimeters it opens and what it takes to close them.
Book a 15-minute call